Thermosensitive Hydrogel In Situ Vaccine for Lymph Node Targeting and Enhanced Immunotherapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Zhengyang Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, P. R. China. Hauptthemen laut MEDLINE: Lymph Nodes, Immunotherapy, Cancer Vaccines, Hydrogels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangzhou Science and Technology Planning Project.
Abstract (Originalsprache)
In situ vaccination is a promising strategy for cancer immunotherapy that enables the convenient induction of diverse tumor antigens directly within a host. However, the immunosuppressive tumor microenvironment markedly impairs the antigen‐presenting capacity of dendritic cells (DCs), resulting in the inefficient presentation of locally generated antigens and, consequently, suboptimal immune responses. To address this challenge, a localized in situ vaccine platform (Gel/MTO&Snp) designed is developed to actively transport tumor‐derived antigens to tumor‐draining lymph nodes (tDLNs), thereby eliciting potent antitumor immunity. Gel/MTO&Snp consists of a thermosensitive hydrogel incorporating subsized PEI/CpG nanocomposite particles (Snp, ≈10 nm) and chemotherapeutic agent mitoxantrone (MTO). Upon near‐infrared (NIR) laser irradiation, Gel/MTO&Snp simultaneously achieved photothermal and chemotherapeutic effects following local injection, thereby inducing immunogenic cell death and triggering antigen release at tumor sites. These liberated antigens are subsequently adsorbed onto positively charged Snp particles and transported via lymphatic vessels to tDLNs in a size‐dependent manner, where they enhanced antigen presentation and immune activation. This targeted antigen delivery markedly promotes DC maturation and effectively stimulates systemic anticancer immunity, providing a novel strategy to optimize the efficacy of in situ cancer vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, P. R. China.
- Department of Radiation Oncology, Affiliated Cancer Hospital&Institute of Guangzhou Medical University, Guangzhou, Guangdong, 510095, P. R. China.
- Department of General Surgery, Guangzhou First People's Hospital, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510180, P. R. China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong, 511442, P. R. China.
- Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, P. R. China.
- Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, P. R. China.
ORCID-Profile: Xianzhu Yang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Guangzhou Science and Technology Planning Project
- the Science and Technology Project of Guangzhou Municipal Health Commission
- the Key Program of the Natural Science Research Foundation for Universities in Anhui Province
Zitieren
APA
Zhao, Z., Liu, H., Li, M., Zheng, Y., Qi, D., Chen, C., Wang, Z., Fu, L., Han, S., Yang, X., Cao, Z., & Li, X. (2026). Thermosensitive Hydrogel In Situ Vaccine for Lymph Node Targeting and Enhanced Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502747
Vancouver
Zhao Z, Liu H, Li M, Zheng Y, Qi D, Chen C, et al. Thermosensitive Hydrogel In Situ Vaccine for Lymph Node Targeting and Enhanced Immunotherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502747
BibTeX
@article{Zhao2026,
author = {Zhao, Zhengyang and Liu, Hao and Li, Min and Zheng, Yunsheng and Qi, Dongli and Chen, Chaoran and Wang, Zilu and Fu, Lijuan and Han, Shuai and Yang, Xianzhu and Cao, Ziyang and Li, Xiaoqiu},
title = {Thermosensitive Hydrogel In Situ Vaccine for Lymph Node Targeting and Enhanced Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502747}
}
EUVIMED